Over $6M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Over $6M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed higher by over 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道瓊斯指數週三收盤上漲超過150點。當內部人士購買或出售股票時，這表明他們對公司前景的信心或擔憂。對細價股感興趣的投資者和交易者可以將此視爲他們整體投資或交易決策的一個因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是細價股最近幾筆值得注意的內幕交易。欲了解更多信息，請查看 本辛加的內幕交易 平台。
OPKO Health
OPKO 健康
- The Trade: OPKO Health, Inc. (NASDAQ:OPK) Chief Innovation Officer Gary Nabel acquired a total of 216,184 shares an average price of $0.93. To acquire these shares, it cost around $200,427.
- What's Happening: OPKO Health recently priced private offering of $200 million convertible senior notes due 2029.
- What OPKO Health Does: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs.
- 貿易：OPKO Health, Inc.（納斯達克股票代碼：OPK）首席創新官加里·納貝爾 共收購了216,184股股票 平均價格爲0.93美元。收購這些股票的成本約爲200,427美元。
- 發生了什麼：OPKO Health最近對2029年到期的2億美元可轉換優先票據的私募發行進行了定價。
- OPKO Health的所作所爲：OPKO Health Inc是一家多元化的生物技術公司，經營藥物和診斷開發項目。
LivePerson
LiveP
- The Trade: LivePerson, Inc. (NASDAQ:LPSN) 10% owner Alexander Slusky acquired a total of 1,805,569 shares at at an average price of $3.49. To acquire these shares, it cost around $6.29 million.
- What's Happening: LivePerson named John Sabino as CEO.
- What LivePerson Does: LivePerson Inc offers cloud-based platform solutions. It enables businesses and consumers to connect through conversational interfaces, such as in-app and mobile messaging, while leveraging bots and Artificial Intelligence (AI) to increase efficiency.
- 交易：LivePerson, Inc.（納斯達克股票代碼：LPSN）10% 的所有者亞歷山大·斯魯斯基 共收購了1,805,569股股票 平均價格爲3.49美元。收購這些股票的成本約爲629萬美元。
- 發生了什麼：LivePerson任命約翰·薩比諾爲首席執行官。
- LivePerson 做什麼：LivePerson Inc提供基於雲的平台解決方案。它使企業和消費者能夠通過對話界面（例如應用程序內和移動消息）進行連接，同時利用機器人和人工智能（AI）來提高效率。
Check This Out: Don't Miss These 3 Energy Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts
看看這個： 千萬不要錯過華爾街最準確的分析師提供的這3只股息收益率超過3％的能源股
Cell MedX
Cell MedX
- The Trade: Cell MedX Corp. (OTC:CMXC) CEO David Jeffs acquired a total of 88,959,726 shares at an average price of $0.01. The insider spent around $622,718 to buy those shares.
- What's Happening: Cell MedX recently entered into agreements to settle debt in the aggregate amount of $1,622,693 for shares at a price of $0.007 per share for an aggregate of 231,813,310 shares of common stock.
- What Cell MedX Does: Cell MedX Corp is an early stage development company focused on the discovery, development and, commercialization of therapeutic products for patients with diseases such as diabetes, by developing technologies to help manage the illness and related complications.
- 交易：Cell MedX Corp.（場外交易代碼：CMXC）首席執行官戴維·傑夫斯 共收購了88,959,726股股票 平均價格爲0.01美元。知情人士花費了約622,718美元購買了這些股票。
- 發生了什麼：Cell MedX最近達成協議，以每股0.007美元的價格償還總額爲1,622,693美元的股票債務，總額爲231,813,310股普通股。
- Cell MedX做什麼：Cell MedX Corp是一家早期開發公司，專注於通過開發有助於管理糖尿病和相關併發症的技術，爲糖尿病等疾病患者發現、開發和商業化治療產品。
Don't forget to check out our premarket coverage here
別忘了在這裏查看我們的上市前報道
譯文內容由第三人軟體翻譯。